A rapid release tablet involves as {TAIL ~ an active ingredient} tolfenamic acid or {HEAD ~ its pharmaceutically acceptable salts} having a mean particle size of <10 μm, alginic acid or its pharmaceutically acceptable salts in an amount of 1.5 6.0% by weight, and a superdisintegrant in an amount of at least 6% by weight 
as
A rapid release tablet involves as { TAIL ~ an active ingredient } tolfenamic acid or { HEAD ~ its pharmaceutically acceptable salts } having a mean particle size of < 10 μm , alginic acid or its pharmaceutically acceptable salts in an amount of 1.5 6.0 % by weight , and a superdisintegrant in an amount of at least 6 % by weight
OTH OTH OTH OTH OTH REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH